Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Neuroscience Methods
|
August 30, 2011
Microscopic magnetic resonance elastography of traumatic brain injury model
Thomas Boulet, Matthew L Kelso, Shadi F Othman
Journal of Neurotrauma
|
March 29, 2013
Long-term in vivo imaging of viscoelastic properties of the mouse brain after controlled cortical impact
Thomas Boulet, Matthew L Kelso, Shadi F Othman
Bulletin Du Cancer
|
December 7, 2007
[Gene expression profiling in cancer research]
Stefan Michiels, S Koscielny, Thomas Boulet, et al.
Journal of Visualized Experiments : Jove
|
February 22, 2012
Magnetic resonance elastography methodology for the evaluation of tissue engineered construct growth
Evan T Curtis, Simeng Zhang, Vahid Khalilzad-Sharghi, et al.
Carcinogenesis
|
May 12, 2007
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers
Stefan Michiels, Patrick Danoy, Philippe Dessen, et al.
International Journal of Cancer
|
May 2, 2008
Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers
Patrick Danoy, Stefan Michiels, Philippe Dessen, et al.
Carcinogenesis
|
February 25, 2009
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk
Stefan Michiels, Agnès Laplanche, Thomas Boulet, et al.
AIDS (London, England)
|
February 18, 2011
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia
Sébastien Gallien, Constance Delaugerre, Isabelle Charreau, et al.
HIV Clinical Trials
|
December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)
Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Breast Cancer Research : BCR
|
January 11, 2023
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
Sanne L de Haas, Dennis J Slamon, Miguel Martin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Neuroscience Methods
|
August 30, 2011
Microscopic magnetic resonance elastography of traumatic brain injury model
Thomas Boulet, Matthew L Kelso, Shadi F Othman
Journal of Neurotrauma
|
March 29, 2013
Long-term in vivo imaging of viscoelastic properties of the mouse brain after controlled cortical impact
Thomas Boulet, Matthew L Kelso, Shadi F Othman
Bulletin Du Cancer
|
December 7, 2007
[Gene expression profiling in cancer research]
Stefan Michiels, S Koscielny, Thomas Boulet, et al.
Journal of Visualized Experiments : Jove
|
February 22, 2012
Magnetic resonance elastography methodology for the evaluation of tissue engineered construct growth
Evan T Curtis, Simeng Zhang, Vahid Khalilzad-Sharghi, et al.
Carcinogenesis
|
May 12, 2007
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers
Stefan Michiels, Patrick Danoy, Philippe Dessen, et al.
International Journal of Cancer
|
May 2, 2008
Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers
Patrick Danoy, Stefan Michiels, Philippe Dessen, et al.
Carcinogenesis
|
February 25, 2009
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk
Stefan Michiels, Agnès Laplanche, Thomas Boulet, et al.
AIDS (London, England)
|
February 18, 2011
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia
Sébastien Gallien, Constance Delaugerre, Isabelle Charreau, et al.
HIV Clinical Trials
|
December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)
Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Breast Cancer Research : BCR
|
January 11, 2023
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
Sanne L de Haas, Dennis J Slamon, Miguel Martin, et al.
Page
of 2